Aubrey De Grey

Dr. de Grey is the biomedical gerontologist who devised the SENS platform, and established SENS Research Foundation to implement it. He works on the development of medical innovations that can postpone all forms of age-related ill-health.

​

His main focus is on rejuvenation: that is, the active repair of the various types of molecular and cellular damage which eventually cause age-related disease and disability, as opposed to the mere retardation of the accumulation of such damage.

He performs this work in his capacity as chief science officer of SENS Research Foundation, a California-based 501(c)(3) charity that undertakes and funds such research; as VP of New Technology Discovery of AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology; and also as editor-in-chief of Rejuvenation Research, the highest-impact peer-reviewed academic journal focused on postponing aging.

He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.